Aubrey Rankin joined Revance Therapeutics board of directors in 2020.
Previously, Mr. Rankin was the co-founder & CEO of HintMD, a fintech platform developed specific for medical aesthetic practices; which was acquired by Revance Therapeutics in 2020.
Prior to co-founding HintMD, Mr. Rankin served as Vice President of Asia-Pacific at ZELTIQ Aesthetics (ZLTQ). During his tenure, he led accelerated growth in the Asia-Pacific region and was part of a larger management team responsible for one of the most successful business turn-around efforts within the medical aesthetics industry.
Mr. Rankin was formerly a Director within PwC’ Mergers and Acquisitions Advisory group, during which he assisted multinational clients on M&A, Divestitures and Strategic Alliance projects ranging from $50M to $3.6B in value. His clients included key Fortune 500, Private Equity, and Silicon Valley start-up companies within software, entertainment, retail and life sciences industries.
Mr. Rankin currently serves as strategic advisor to the board of directors of Sciton, PB&B, and FriendMedia. He holds an MBA from Strayer University and a B.Sc. degree from the University of Stellenbosch.